EMEA-002565-PIP02-19-M01 - paediatric investigation plan
Difelikefalin
PIPHuman
Key facts
- Active Substance
- Difelikefalin
- Therapeutic area
- Other
- Decision number
- P/0058/2024
- PIP number
- EMEA-002565-PIP02-19-M01
- Pharmaceutical form(s)
- Solution for injection/infusion
- Condition(s) / indication(s)
- Treatment of chronic kidney disease associated pruritus
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Vifor Fresenius Medical Care Renal Pharma France
Tel. +41 588518000
E-mail: difelikefalin_ra@viforpharma.com- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date